4.7 Article

Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A Chinese multi-center prospective randomized controlled trial

Related references

Note: Only part of the references are listed.
Article Oncology

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Eva Versteijne et al.

Summary: This study investigates the impact of neoadjuvant chemoradiotherapy on the survival of patients with resectable and borderline resectable pancreatic cancer. The results demonstrate that neoadjuvant chemoradiotherapy improves overall survival compared to upfront surgery in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Biotechnology & Applied Microbiology

Comparison of clinical usefulness of serum Ca125 and CA19-9 in pancreatic adenocarcinoma diagnosis: meta-analysis and systematic review of literature

Aleksander Skulimowski et al.

Summary: The meta-analysis comparing Ca125 and CA19-9 showed that Ca125 has a slightly higher specificity than CA19-9, while combined tests (CA19-9 + Ca125) models are generally characterized by higher sensitivity.

BIOMARKERS (2021)

Article Surgery

Predictive Values of Preoperative Markers for Resectable Pancreatic Body and Tail Cancer Determined by MDCT to Detect Occult Metastases

He Cheng et al.

Summary: The study suggests that CA125 is more effective than CA19-9 and tumor size in predicting occult metastases in resectable pancreatic body and tail cancer indicated by MDCT scans. A high level of CA125 (>=22.1 U/ml) is considered a risk factor for occult metastases, suggesting laparoscopy for these patients.

WORLD JOURNAL OF SURGERY (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Surgery

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

Guopei Luo et al.

ANNALS OF SURGERY (2017)

Article Medicine, General & Internal

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial

Helmut Oettle et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)